9. Jensen, R.A., Thompson, M.E., Jetton, T.L., Szabo, C.I., van der Meer, R., Helou, В., Tronick, S., King, M.C., Page, D.L. and Holt, J.T., 1996. BRCA1 is secreted and exhibits properties of a granin.
10. Struewing, J.P., Abeliovich, D., Peretz, Т., Avishai, N., Kaback, M.M., Collins, F.S. and Brody, L.C., 1995. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi-Jewish individuals.
http://rex.nci.nih.gov/massmedia/back-grounders/ashkenazi.html
11. Roa, B.B., Boyd, A.A., Volcik, K. and Richards, C.S., 1996. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.
12. www.mercola.com/2002/apr/27/sv40.htm
13. Hursting, S.D., Slaga,T.J., Fischer, S.M., DiGiovanni, J. and Phtans, J. M., 1999. Mechanism-based cancer prevention approaches: targets, examples, and the use of transgenic mice.
14. Cheeseman, K.H. and Slater, T.F., 1993.
15. Cheesernan, K.H. and Slater, T.F., 1993.
16. Stewart, H.J., 1989. Clinical experience in the use of antioestrogen tamoxifen in the treatment of breast cancer.
17. Miller, W R., 1997. Aromatase inhibitors and breast cancer.
18. Dao, T.L., Sinha, D.K., Nemato, T. and Patel, J., 1982. Effects of estrogens and progesterone on cellular replication of human breast tumours.
19. Conte, P.P., Fraschini, G. and Dewinko, B., 1985. Estrogen induced expansion of the growth fraction in receptor negative human breast cancer
20. Miller, WR. and Langdon, S.P., 1997. Hormonal, growth factor and cytokine control of breast cancer. In:
21. Miller, WR., 1991. Oestrogens and breast cancer: biological considerations,
22. Yu, H. and Rohan, Т., 2002. Role of the insulin-like growth factor family in cancer development and progression.
23. Rose, Steven, with Mileusnic, Radmila, 1999.
24. Voet, Donald and Voet, Judith, 1995.
25. Jiang, Wen G., Matsumoto, Kunio and Nakamura, Toshikazu (editors), 2001,
26. Yu, H. and Rohan, Т., 2002. Role of the insulin-like growth factor family in cancer development and progression.
27. Yu, H. and Rohan, Т., 2002. Role of the insulin-like growth factor family in cancer development and progression.
28. www.ucop.edu/srphome/bcrp/progressreport/abstracts/ innov/3CB-0186.html
29. Yu, H. and Rohan, Т., 2002. Role of the insulin-like growth factor family in cancer development and progression.
30. www.preventcancer.com/pdf/InsulinGrowth266.html
Дополнение к главе 3
1. www.dep.iarc.fr/globocan/database.pdf
2. WHO International Agency for Research on Cancer (IARC), IARC Cancer Epidemiology Database. GLOBOCAN 2000. Cancer incidence, mortality and prevalence worldwide. Ferlay, J., Bray, F., Piesci, P. and Parkin, D.M. (editors), www.dep.iarc. fr/globocan/ database.pdf
3. American Cancer Society. Modelled data: cancer facts and figures, 2006.
4. www.cancerresearchuk.org
5. www.cancerresearchuk.org
6. www.cancerresearchuk.org